Dr. Victor Gurewich believes he has a better way to treat strokes and heart attacks. But no one wants to hear it.
The 88-year-old Harvard Medical School professor just wants to publicize and test what could be a groundbreaking treatment, but he has struggled to be taken seriously, Stat News detailed in a report published Friday. Gurewich's treatment combines two medications to quickly break clots and reduce potential brain damage until a patient can receive angioplasty, which pushes a clot away for good.
Gurewich ran a clinical trial on the treatment 23 years ago, but the company that ran it shut down. Instead of Gurewich's method, a drug called tPA rose to prominence.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But tPA often causes seizures and brain bleeds, making some doctors afraid to use it. Gurewich thinks he could produce a safer alternative, and with his research, he should've be able to find funding for another clinical trial by now. But some professionals shoot down Gurewich's idea, saying it's out of date. Others have never even heard it.
But when Stat explained Gurewich's proposal to one medical professional, the doctor said it was a "nifty idea," and "maybe" even a "great" one. Gurewich has some other staunch supporters who "believe in the science" behind his work.
One foundation has kept Gurewich's company afloat for years, and it's finally helping his treatment take the next step: A clinical trial of 100 patients will start in the Netherlands this June. With more funding, the treatment should get a second trial in London. Read more about Gurewich's unending determination at Stat News.
-
What is Donald Trump planning in Latin America?Today’s Big Question US ramps up feud with Colombia over drug trade, while deploying military in the Caribbean to attack ships and increase tensions with Venezuela
-
How the online world relies on AWS cloud serversThe Explainer Chaos caused by Monday’s online outage shows that ‘when AWS sneezes, half the internet catches the flu’
-
Leonard and Hungry Paul: ‘beautiful, heartfelt’ televisionThe Week Recommends Julia Roberts narrates this ‘charming’ and ‘unexpectedly profound’ adaptation of Rónán Hession’s novel
-
Bolivia elects centrist over far-right presidential rivalSpeed Read Relative political unknown Rodrigo Paz, a centrist senator, was elected president
-
Madagascar president in hiding, refuses to resignSpeed Read Andry Rajoelina fled the country amid Gen Z protests and unrest
-
Sanae Takaichi: Japan’s Iron Lady set to be the country’s first woman prime ministerIn the Spotlight Takaichi is a member of Japan’s conservative, nationalist Liberal Democratic Party
-
Israel, Hamas agree to first step of Trump peace planSpeed Read Israel’s military pulls back in Gaza amid prisoner exchange
-
Israel intercepts 2nd Gaza aid flotilla in a weekSpeed Read The Israeli military intercepted a flotilla of nine boats with 145 activists aboard along with medical and food aid
-
Japan poised to get first woman prime ministerSpeed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
Israel and Hamas meet on hostages, Trump’s planSpeed Read Hamas accepted the general terms of Trump’s 20-point plan, including the release of all remaining hostages
-
US tipped to help Kyiv strike Russian energy sitesSpeed Read Trump has approved providing Ukraine with intelligence for missile strikes on Russian energy infrastructure
